Patterns of viral dynamics during primary human immunodeficiency virus type 1 infection

Journal of Infectious Diseases

Volumn 178, Issue 6, 1998, Pages 1812-1815

  Kaufmann, Gilbert R ^a   Cunningham, Philip ^a   Kelleher, Anthony D ^a,b   Zaunders, John ^a   Carr, Andrew ^a   Vizzard, Jeanette ^a   Law, Matthew ^a   Cooper, David A ^a,c  

^a ST VINCENT S HOSPITAL   (Australia)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VIRUS LOAD;

ADULT; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE COUNT; MALE; MODELS, THEORETICAL; RETROSPECTIVE STUDIES; RNA, VIRAL; TIME FACTORS; VIRAL LOAD;

EID: 0031736294     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314480     Document Type: Article

References (15)

1. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 1996;271:1582-6.
2. Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995;373:117-22.
3. Daar ES, Moudgil T, Meyer RD, Ho DD. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N Engl J Med 1991;324:961-4.
4. Graziosi C, Pantaleo G, Butini L, et al. Kinetics of human immunodeficiency virus type 1 (HIV-1) DNA and RNA synthesis during primary HIV-1 infection. Proc Natl Acad Sci USA 1993;90:6405-9.
5. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HIV-1 RNA plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
6. + T-cell determinations in persons with human immunodeficiency virus infection. MMWR Morb Mortal Wkly Rep 1992;1(RR-8):1-17.
7. Gibaldi M, Perrier D. Pharmacokinetics. Vol 15. 2nd ed. New York: Marcel Dekker, 1982:45-111.
8. Reich JG. Curve fitting and modelling for scientists and engineers. New York: McGraw-Hill, 1992:179-210.
9. Schacker TW, Hughes JP, Shea T, Coombs RW, Corey L. Biological and virologie characteristics of primary HIV infection. Ann Intern Med 1998;128:613-20.
10. Kinloch-De Loes S, Hirschel BJ, Hoen B, et al. A controlled trial of zidovudine in primary human immunodeficiency virus type 1 infection. N Engl J Med 1995;333:408-13.
11. Nowak M, Lloyd A, Vasquez GM, et al. Viral dynamics of primary viremia and antiretroviral therapy in simian immunodeficiency virus infection. J Virol 1997;71:7518-25.
12. Borrow P, Lewicki H, Wei X, et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTL) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med 1997;3:205-11.
13. Price DA, Goulder PJR, Klenerman P, et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc Natl Acad Sci USA 1997;94:1890-5.
14. Nowak MA, Bangham CR. Population dynamics of immune responses to persistent viruses. Science 1996;272:74-9.
15. Nowak MA, May RM, Phillips RE, et al. Antigenic oscillations and shifting immunodominance in HIV-1 infections. Nature 1995;375:606-11.